Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1835-1843, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (211)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, Y.
Right arrow Articles by Wright, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, Y.
Right arrow Articles by Wright, G. L., Jr.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Oak Ridge Conference
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2002;48:1835-1843.)
© 2002 American Association for Clinical Chemistry, Inc.

Oak Ridge Conference

Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients

Yinsheng Qu1, Bao-Ling Adam2,4, Yutaka Yasui1, Michael D. Ward2,4, Lisa H. Cazares2,4, Paul F. Schellhammer2,3,4, Ziding Feng1, O. John Semmes2,4 and George L. Wright, Jr.2,3,4a

1 Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Departments of
2 Microbiology and Molecular Cell Biology and
3 Urology, Eastern Virginia Medical School, Norfolk, VA 23501.

4 Virginia Prostate Center, Eastern Virginia Medical School and Sentara Cancer Institute, Norfolk, VA 23501.

aAddress correspondence to this author at: Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, 700 West Olney Rd., Norfolk, VA 23507. Fax 757-624-2255; e-mail wrightgl{at}evms.edu.


Abstract

Background: The low specificity of the prostate-specific antigen (PSA) test makes it a poor biomarker for early detection of prostate cancer (PCA). Because single biomarkers most likely will not be found that are expressed by all genetic forms of PCA, we evaluated and developed a proteomic approach for the simultaneous detection and analysis of multiple proteins for the differentiation of PCA from noncancer patients.

Methods: Serum samples from 386 men [197 with PCA, 92 with benign prostatic hyperplasia (BPH), and 96 healthy individuals], randomly divided into training (n = 326) and test (n = 60) sets, were analyzed by surface-enhanced laser desorption/ionization (SELDI) mass spectrometry. The 124 peaks detected by computer analyses were analyzed in the training set by a boosting tree algorithm to develop a classifier for separating PCA from the noncancer groups. The classifier was then challenged with the test set (30 PCA samples, 15 BPH samples, 15 samples from healthy men) to determine the validity and accuracy of the classification system.

Results: Two classifiers were developed. The AdaBoost classifier completely separated the PCA from the noncancer samples, achieving 100% sensitivity and specificity. The second classifier, the Boosted Decision Stump Feature Selection classifier, was easier to interpret and used only 21 (compared with 74) peaks and a combination of 21 (vs 500) base classifiers to achieve a sensitivity and specificity of 97% for the test set.

Conclusions: The high sensitivity and specificity achieved in this study provides support of the potential for SELDI, coupled with a bioinformatics learning algorithm, to improve the early detection/diagnosis of PCA.




The following articles in journals at HighWire Press have cited this article:


Home page
 Evid Based Complement Alternat MedHome page
C. Matsumoto, T. Kojima, K. Ogawa, S. Kamegai, T. Oyama, Y. Shibagaki, T. Kawasaki, H. Fujinaga, K. Takahashi, H. Hikiami, et al.
A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine
Evid. Based Complement. Altern. Med., December 1, 2008; 5(4): 463 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Sardana, B. Dowell, and E. P. Diamandis
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Clin. Chem., December 1, 2008; 54(12): 1951 - 1960.
[Abstract] [Full Text] [PDF]

Home page
 Brief BioinformHome page
M. Hilario and A. Kalousis
Approaches to dimensionality reduction in proteomic biomarker studies
Brief Bioinform, March 1, 2008; 9(2): 102 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. McLerran, W. E. Grizzle, Z. Feng, W. L. Bigbee, L. L. Banez, L. H. Cazares, D. W. Chan, J. Diaz, E. Izbicka, J. Kagan, et al.
Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample Bias
Clin. Chem., January 1, 2008; 54(1): 44 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. McLerran, W. E. Grizzle, Z. Feng, I. M. Thompson, W. L. Bigbee, L. H. Cazares, D. W. Chan, J. Dahlgren, J. Diaz, J. Kagan, et al.
SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer
Clin. Chem., January 1, 2008; 54(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
Z. Wang, Y.-c. I. Chang, Z. Ying, L. Zhu, and Y. Yang
A parsimonious threshold-independent protein feature selection method through the area under receiver operating characteristic curve
Bioinformatics, October 15, 2007; 23(20): 2788 - 2794.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Bouamrani, J. Ternier, D. Ratel, A.-L. Benabid, J.-P. Issartel, E. Brambilla, and F. Berger
Direct-Tissue SELDI-TOF Mass Spectrometry Analysis: A New Application for Clinical Proteomics
Clin. Chem., November 1, 2006; 52(11): 2103 - 2106.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Jahnukainen, D. Malehorn, M. Sun, J. Lyons-Weiler, W. Bigbee, G. Gupta, R. Shapiro, P. S. Randhawa, R. Pelikan, M. Hauskrecht, et al.
Proteomic Analysis of Urine in Kidney Transplant Patients with BK Virus Nephropathy
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3248 - 3256.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
L. J. Dekker, W. Boogerd, G. Stockhammer, J. C. Dalebout, I. Siccama, P. Zheng, J. M. Bonfrer, J. J. Verschuuren, G. Jenster, M. M. Verbeek, et al.
MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast Cancer
Mol. Cell. Proteomics, September 1, 2005; 4(9): 1341 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
P. Geurts, M. Fillet, D. de Seny, M.-A. Meuwis, M. Malaise, M.-P. Merville, and L. Wehenkel
Proteomic mass spectra classification using decision tree based ensemble methods
Bioinformatics, July 15, 2005; 21(14): 3138 - 3145.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Kim, P. Sun, Y.-W. Lam, P. Troncoso, A. L. Sabichi, R. J. Babaian, L. L. Pisters, C. A. Pettaway, C. G. Wood, S. M. Lippman, et al.
Changes in Serum Proteomic Patterns by Presurgical {alpha}-Tocopherol and L-Selenomethionine Supplementation in Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1697 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F M Brouwers, E F Petricoin III, L Ksinantova, J Breza, V Rajapakse, S Ross, D Johann, M Mannelli, B L Shulkin, R Kvetnansky, et al.
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
Endocr. Relat. Cancer, June 1, 2005; 12(2): 263 - 272.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
J. S. Yu, S. Ongarello, R. Fiedler, X. W. Chen, G. Toffolo, C. Cobelli, and Z. Trajanoski
Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data
Bioinformatics, May 15, 2005; 21(10): 2200 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
M. E. Wright, D. K. Han, and R. Aebersold
Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer
Mol. Cell. Proteomics, April 1, 2005; 4(4): 545 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. Listgarten and A. Emili
Statistical and Computational Methods for Comparative Proteomic Profiling Using Liquid Chromatography-Tandem Mass Spectrometry
Mol. Cell. Proteomics, April 1, 2005; 4(4): 419 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. Le, K. Chi, S. Tyldesley, S. Flibotte, D. L. Diamond, M. A. Kuzyk, and M. D. Sadar
Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions
Clin. Chem., April 1, 2005; 51(4): 695 - 707.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Malik, M. D. Ward, S. K. Gupta, M. W. Trosset, W. E. Grizzle, B.-L. Adam, J. I. Diaz, and O. J. Semmes
Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1073 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
O. J. Semmes, Z. Feng, B.-L. Adam, L. L. Banez, W. L. Bigbee, D. Campos, L. H. Cazares, D. W. Chan, W. E. Grizzle, E. Izbicka, et al.
Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility
Clin. Chem., January 1, 2005; 51(1): 102 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-d. Chen, S. Zheng, J.-k. Yu, and X. Hu
Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population
Clin. Cancer Res., December 15, 2004; 10(24): 8380 - 8385.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. Hood, J. R. Heath, M. E. Phelps, and B. Lin
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
Science, October 22, 2004; 306(5696): 640 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, R. C. Bast Jr., Y. Yu, J. Li, L. J. Sokoll, A. J. Rai, J. M. Rosenzweig, B. Cameron, Y. Y. Wang, X.-Y. Meng, et al.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Cancer Res., August 15, 2004; 64(16): 5882 - 5890.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Vlahou, A. Giannopoulos, B. W. Gregory, T. Manousakas, F. I. Kondylis, L. L. Wilson, P. F. Schellhammer, G. L. Wright Jr, and O. J. Semmes
Protein Profiling in Urine for the Diagnosis of Bladder Cancer
Clin. Chem., August 1, 2004; 50(8): 1438 - 1441.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. E. Grizzle, S. Meleth, E. F. Petricoin, and L. A. Liotta
Clarification in the Point/Counterpoint Discussion Related to Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometric Identification of Patients with Adenocarcinomas of the Prostate * Proteomic Pattern Complexity Reveals a Rich and Uncharted Continent of Biomarkers
Clin. Chem., August 1, 2004; 50(8): 1475 - 1477.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. G. Soltys, Q.-T. Le, G. Shi, R. Tibshirani, A. J. Giaccia, and A. C. Koong
The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers
Clin. Cancer Res., July 15, 2004; 10(14): 4806 - 4812.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Wolfe, J. Murphy, J. McGinley, Z. Zhu, W. Jiang, E. B. Gottschall, and H. J. Thompson
Using Nuclear Morphometry to Discriminate the Tumorigenic Potential of Cells: A Comparison of Statistical Methods
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 976 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
E. P. Diamandis
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations
Mol. Cell. Proteomics, April 1, 2004; 3(4): 367 - 378.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. P. Diamandis
Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems
J Natl Cancer Inst, March 3, 2004; 96(5): 353 - 356.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Rogers, P. Clarke, J. Noble, N. P. Munro, A. Paul, P. J. Selby, and R. E. Banks
Proteomic Profiling of Urinary Proteins in Renal Cancer by Surface Enhanced Laser Desorption Ionization and Neural-Network Analysis: Identification of Key Issues Affecting Potential Clinical Utility
Cancer Res., October 15, 2003; 63(20): 6971 - 6983.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. R. Coombes, H. A. Fritsche Jr, C. Clarke, J.-n. Chen, K. A. Baggerly, J. S. Morris, L.-c. Xiao, M.-C. Hung, and H. M. Kuerer
Quality Control and Peak Finding for Proteomics Data Collected from Nipple Aspirate Fluid by Surface-Enhanced Laser Desorption and Ionization
Clin. Chem., October 1, 2003; 49(10): 1615 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. P. Diamandis
Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?
Clin. Chem., August 1, 2003; 49(8): 1272 - 1275.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. F. Petricoin III and L. A. Liotta
RESPONSE: Re: Serum Proteomic Patterns for Detection of Prostate Cancer
J Natl Cancer Inst, March 19, 2003; 95(6): 490 - 491.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.